PRODUCTION OF UDP-GALNAC
    1.
    发明专利

    公开(公告)号:JPH1146789A

    公开(公告)日:1999-02-23

    申请号:JP21490197

    申请日:1997-08-08

    Applicant: TOMITA PHARMA

    Abstract: PROBLEM TO BE SOLVED: To obtain the subject compound useful for the development of medicines, etc. at a low cost on a large seale by allowing an epimerase to act on VDP-GlcNac and subsequently applying a column to the product to separate the compound from the raw material, wherein a lectin capable of selectively binding to the compound is immobilized on the column. SOLUTION: This method for producing VDP-GalNAc comprises allowing an epimerase to act on VDP-GlcNAc to convert into the VDP-GalNAc, subjecting the reaction mixture to a column to separate the VDP-GalNAc from the VDP-GlcNAc. A lectin capable of selectively binding to the VDP-GalNAc is immobilized on the column. Thus, the objective VDP-GalNAc can be obtained at a low cost on a large scale. Dolichosbiflorus agglutinin(DBA), Griffonia simplicifolia agglutinin(GSA), Helix pomatia agglutinin(HPA), etc., are desirably used as the lectin capable of selectively binding to the VDP-GalNAc.

    PRODUCTION OF MAGNESIUM HYDROGEN CITRATE PENTAHYDRATE

    公开(公告)号:JPH06228046A

    公开(公告)日:1994-08-16

    申请号:JP1855393

    申请日:1993-02-05

    Applicant: TOMITA PHARMA

    Abstract: PURPOSE:To provide a production process for magnesium citrate pentahydrate which is excellent in solubilization and storability. CONSTITUTION:Magnesium metal or its salt is allowed to react with citric acid and the reaction product is precipitated to give magnesium hydrogen citrate pentahydrate wherein the citric acid is used in 1.1 to 1.8 mole per mole of magnesium metal or its salt.

Patent Agency Ranking